Resilience Therapeutics
Duxbury, US · Founded 2014 · Delaware corporation
Founders & leadership
JR
Jeffrey R SabadosExecutive
RM
Retsina M MeyerNamed on SEC filing
Board
JE
Jason E FullerBoard director
WC
William CowanBoard director
Reported raises · per SEC filings
Form D private placements$3.4M disclosed across 2 rounds · 2015–2016
▶$500KraisedMar 2016 · 1 investors · PharmaceuticalsRule 506(b)
▶$500KraisedMar 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jason E FullerDirector
- Jeffrey R SabadosExecutive Officer, Director
- William M CowanDirector
- Offering amount
- $10M
- Amount sold
- $500K
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$2.9MraisedJul 2015 · 32 investors · PharmaceuticalsRule 506(b)
▶$2.9MraisedJul 2015 · 32 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jason E FullerDirector
- William CowanDirector
- Retsina M MeyerExecutive Officer
- Jeffrey R SabadosExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $2.9M
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Resilience Therapeutics raised?
- Resilience Therapeutics has disclosed $3.4M raised across 2 rounds.
- Where is Resilience Therapeutics headquartered?
- Resilience Therapeutics is headquartered in Duxbury, US.